Clinical Services Lab | GenomeWeb

Clinical Services Lab

Short Reads

Premium

Life Technologies, J. Craig Venter Institute, BioNanomatrix, Nanosys, Geospiza, HDF Group, Pressure BioSciences, Cofactor Genomics, Ambry Genetics, Affymetrix, Navigenics, Enzymatics, New York State Department of Health, University of Washington

Navigenics decided to acquire Affy’s 10,000-square-foot Clinical Services Lab in Sacramento, Calif., after seeing an increase in the volume of orders for its genetic screening service. In addition to the advantages of having an internal CLIA lab, however, the consumer genomics firm will now have to navigate a complex regulatory environment.

Affy has decided to refocus its efforts on its core microarray platform and being an enabler for the broad adoption of microarrays across all genetic analysis markets, including CLIA lab services. Meanwhile, Navigenics takes over ownership of the lab as the volume of orders for its genetic screening service has increased.

Affy transferred ownership of the 10,000-square-foot Clinical Services Lab to Navigenics earlier this year though an increasing number of drug makers outsource their molecular diagnostic research needs to CLIA labs.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.